1. Control of cardiac energetics: from models to human disease

   • James C. A. Hopkins
   • Kieran Clarke
   • George K. Radda

   OriginalPaper 17 September 2013 Pages: 1 - 2

2. Multinuclear MR-spectroscopy on ion-homeostasis and energetics during ischemia and reperfusion

   • Ulrich K. M. Decking
   • Lars Vogler
   • Jürgen Schrader

   OriginalPaper 17 September 2013 Pages: 3 - 4

3. Intracellular sodium in the ischemic and reperfused heart and its role in injury

   • M. Bernard
   • E. Cabanes
   • D. Feuvray

   OriginalPaper 17 September 2013 Pages: 5 - 6

4. Muscular dystrophy: from gene to patient

   • James C. A. Hopkins
   • Britta L. Bia
   • Kieran Clarke

   OriginalPaper 17 September 2013 Pages: 7 - 9

5. Cardiovascular phenotype characterization in mice by high resolution magnetic resonance imaging

   • Frank Wiesmann
   • Jan Ruff
   • Stefan Neubauer

   OriginalPaper 17 September 2013 Pages: 10 - 15

6. The diagnostic impact of 2D- versus 3D- left ventricular volumetry by MRI in patients with suspected heart failure

   • Matthias G. Friedrich
   • Jeanette Schulz-Menger
   • Rainer Dietz

   OriginalPaper 17 September 2013 Pages: 16 - 19

7. In vivo functional and MRS metabolic evaluation of the heart graft; application to improvements of cardiac preservation

   • Thierry Caus
   • Marguerite Izquierdo
   • Monique Bernard

   OriginalPaper 17 September 2013 Pages: 20 - 22

8. In vivo and in vitro³¹P MRS studies on myocardial energy metabolism of brain dead cats

   • G. J. Brandon Bravo Bruinsma
   • J. J. Bredée
   • C. J. A. Van Echteld

   OriginalPaper 17 September 2013 Pages: 23 - 26

9. Detection of acute cardiac rejection by high resolution proton magnetic resonance spectroscopy of plasma

   • A. Mouly-Bandini
   • J. Vion-Dury
   • P. J. Cozzone

   OriginalPaper 17 September 2013 Pages: 27 - 32

10. In-vivo cardiac studies in animals using magnetic resonance techniques: experimental aspects and MR readouts

    • Markus Rudin
    • Peter R. Allegrini
    • Didier Laurent

    OriginalPaper 17 September 2013 Pages: 33 - 35

11. Methodological advances in cardiac³¹P-MR spectroscopy

    • Markus von Kienlin

    OriginalPaper 17 September 2013 Pages: 36 - 38

12. Quantification and imaging of myocardial sodium and creatine kinase metabolites

    • Paul A. Bottomley
    • Ray F. Lee
    • Robert G. Weiss

    OriginalPaper 17 September 2013 Pages: 39 - 41

13. Use of²³Na MRS to discriminate viable from non viable tissue: experimental studies

    • Michael Horn
    • Claudia Weidensteiner
    • Stefan Neubauer

    OriginalPaper 17 September 2013 Pages: 42 - 43

14. Assessment of myocardial viability by³¹P-MR-spectroscopy and²³Na-MR imaging

    • Meinrad Beer
    • J. Sandstede
    • D. Hahn

    OriginalPaper 17 September 2013 Pages: 44 - 46

15. Myocardial viability assessed with tagged MRI

    • P. Croisille

    OriginalPaper 17 September 2013 Pages: 47 - 48

16. Cardiovascular MRI probes for the outside in and for the inside out

    • Paul A. Bottomley
    • Ergin Atalar
    • Albert Lardo

    OriginalPaper 17 September 2013 Pages: 49 - 51

17. High speed and high resolution cardiac MRI (parallel acquisition techniques & modular imaging)

    • P. M. Jakob
    • M. Griswold
    • A. Haase

    OriginalPaper 17 September 2013 Pages: 52 - 54

18. From flow to pressure: estimation of pressure gradient and derivative by MR acceleration mapping

    • Jean-Pierre Tasu
    • Odile Jolivet
    • Jacques Bittoun

    OriginalPaper 17 September 2013 Pages: 55 - 57

19. Microimaging of atherosclerotic plaque in animal models

    • Linda Chaabane
    • E. Canet
    • A. Briguet

    OriginalPaper 17 September 2013 Pages: 58 - 60

20. Novel revascularization therapies — TMLR and growth factor-induced angiogenesis monitored with cardiac MRI

    • Norbert M. Wilke
    • Andrey Zenovich
    • Michael Jerosch-Herold

    OriginalPaper 17 September 2013 Pages: 61 - 64

21. The intravascular contrast agent Clariscan™ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease

    • Christoph Klein
    • Eike Nagel
    • Eckart Fleck

    OriginalPaper 17 September 2013 Pages: 65 - 67

22. Functional MRA

    • J. Hennig
    • R. Strecker

    OriginalPaper 17 September 2013 Pages: 68 - 70

23. MR perfusion imaging: correlation with PET and quantitative angiography

    • J. Schwitter
    • G. K. von Schulthess

    OriginalPaper 17 September 2013 Pages: 71 - 72

24. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium

    • Stefan Neubauer
    • Meinrad Beer
    • Dietbert Hahn

    OriginalPaper 17 September 2013 Pages: 73 - 74

25. Functional and metabolic consequences of aortic valve replacement

    • Hildo J. Lamb

    OriginalPaper 17 September 2013 Pages: 75 - 77

26. MRI for follow-up after surgery for thoracic aorta dissection

    • Jean-Yves Gaubert
    • Thierry Caus
    • Jean-Michel Bartoli

    OriginalPaper 17 September 2013 Pages: 78 - 79

27. Na⁺-overload during ischemia and reperfusion in rat hearts: comparison of the Na⁺/H⁺-exchange blockers EIPA, HOE642 and EMD96785

    • Michiel ten Hove
    • Jan G. van Emous
    • Cees J. A. van Echteld

    OriginalPaper 17 September 2013 Pages: 80 - 81

28. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging

    • Jeanette Schulz-Menger
    • Oliver Strohm
    • Matthias G. Friedrich

    OriginalPaper 17 September 2013 Pages: 82 - 83

29. Assessment of mulibrey nanism cardiopathy with functional magnetic resonance imaging

    • S. Kokki
    • K. Lauerma
    • P. Hekali

    OriginalPaper 17 September 2013 Pages: 84 - 86

30. A model-based method for myocardium flow estimation

    • M. F. Santarelli
    • L. Landini
    • A. Benassi

    OriginalPaper 17 September 2013 Pages: 87 - 88